ACE and COVID-19: Cell cultures of human alveolar type II cells with vitamin D have demonstrated that the virus binds to the ACE2 receptor and reduces its activity and, in turn, promotes ACE1 activity, forming more angiotensin II, which increases the severity of COVID-19 [26].